European Archives - Page 57 of 1607 - European Medical Journal

Hospital-at-Home Supported Safe Kidney Transplant Recovery

Early Hospital-at-Home transfer after kidney transplant reduced hospital stay and healthcare costs while maintaining comparable one-year clinical outcomes, graft survival and readmission rates in a propensity score matched study.

First Human Trial Begins for Bundibugyo Ebola Vaccine

First human trials for Bundibugyo ebolavirus vaccine begin amid a deadly outbreak in the Democratic Republic of Congo.

Protein Breakfast Offset Genetic Glucose Response Risk

A randomised crossover trial found that individuals with the MTNR1B GG genotype had a greater glucose response to a carbohydrate rich breakfast, while a protein enriched breakfast eliminated significant genotype differences.

Patients with IBD Report Gaps in Sexuality Discussions

A qualitative study found sexuality discussions in inflammatory bowel disease care were often absent, with patients reporting unmet information needs and identifying trust and clinician competence as essential for meaningful conversations.

Flexible Cystoscopy Costs Favoured Reusable Devices

A real-world outpatient analysis found reusable flexible cystoscopes were markedly cheaper per procedure than single-use devices, although nursing staff strongly preferred the workflow advantages of single-use systems.

Diabetes Technology Introduced New Patient Challenges

Modern diabetes technology brought new challenges, including device waste, travel, insurance hurdles, and digital security concerns.

Liberal Transfusion Reduced Myocardial Infarction Risk

A post hoc analysis suggested that a liberal transfusion strategy offered an overall clinical benefit for patients with myocardial infarction and anaemia by reducing death or recurrent myocardial infarction.

BMS office building

12 years after Pfizer, AstraZeneca reaches for BMS

The deal would rank among the largest in pharmaceutical history.

UK Breast Cancer Screening Programme Missing 95% of High-Risk Women

Current NHS breast cancer referral criteria may miss up to 95% of at-risk women under 50, a new study finds.

From Innovation to Impact in Digital Health: Interview with Lloyd Humphreys

Why do great digital health innovations never scale? Lloyd Humphreys shares what the industry gets wrong.